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Allied Disciplines
Stephen M. Krane, MD*

n the course of planning the 1988 Intemational Bone and Mineral Symposium, several of us thought it would be valuable to
discuss certain problems of the skeleton that might not be considered to be related to what have been perhaps arbitrarily defined as metabolic bone diseases. We reasoned that principles
are emerging from recent research that eventually might be applicable to the care of patients with these diseases or understanding pathogenesis.
There is little question that in order to maintain exquisite control of skeletal metabolism it will be necessary to establish what
factors regulate the function of bone cells and their interactions.
For example, regulation of the rate at which osteoblasts deposit
bone matrix and effect its mineralization is critical for maintenance of adequate bone mass during remodeling and the degree
and quality of repair in response to injury or tumor. The quality
and amount of the organic matrix deposited in bone are critical
as demonstrated by the profound pathological consequences of
single amino acid substitution in the helical portion of the type I
collagen chains in instances of osteogenesis imperfecta.

I

Application of Molecular Genetics to
Osteopenic Bone Disease
Tsipouras and Rowe (1) presented an analysis ofthe genetic
approach to understanding collagen structure and synthesis
in human disease, particularly the use of analysis of restriction fragment length polymorphisms. This technique has
made it possible to demonstrate linkage in several kindreds with
multiple members affected with some forms of osteogenesis
imperfecta.

Bone Induction
Glowacki (2) described what is known about some of the
mechanisms that govem induction of new bone, particularly the
system in which the endochondral sequence is induced by implantation of fragments of demineralized bone. This model, describedfirstby Urist and Huggins, not only permits dissection of
controls at each phase in the sequence, but application of some
of the principles derived from its study also provides new
therapeutic approaches to such clinical problems as nonunion
of fractures and reconstitution of various types of skeletal
discontinuity.

tors involved been isolated, the cDNAs cloned and expressed
and their receptors characterized, but sufficient quantities of the
recombinant polypeptides are available specifically to treat
some anemias and neutropenias. Sufficient promise has now
been shown using some of these colony stimulating-factors to
relieve the bone marrow failure after irradiation or chemotherapy. Osteoclasts are also derived from hematopoietic precursors, and knowledge of factors that govem the differentiation of
these cells is critical to understanding physiological and pathological bone resorption. Roodman (3) presented an up-to-date
general description of hematopoietic growth factors, particularly in the context of therapeutic potential and the relationship
to osteoclast differentiation.

Musculoskeletal Magnetic Resonance Imaging
The introduction of computed tomography and magnetic resonance imaging has revolutionized clinical care by providing
more accurate means for assessing the type and extent of all
sorts of pathological lesions in soft tissues. The application of
magnetic resonance imaging techniques to analysis of musculoskeletal disorders has recently been achieved. Dr. Murphy
from the Mallinkrodt Institute of Radiology at Washington University in St. Louis discussed some of his experience with musculoskeletal magnetic resonance imaging to illustrate the power
of the method.

Surgical Management of Patients
with Skeletal Thmors
Bone tumors are rare, and physicians who care for adults with
metabolic bone diseases usually do not have the chance to develop any experience in the diagnosis or management of these
neoplasms. Even in patients with Paget disease, osteosarcomas
develop as a complication of the skeletal lesions with a frequency of well under 1%. Nevertheless, these are still important
cancers in pediatric orthopedic practice, and there has been considerable improvement in outlook as a result of better procedures to evaluate the lesions and proper appreciation of the
usefulness of surgery and chemotherapy. Understanding the biology of osteosarcomas will provide us with useful information
about the biology of osteoblasts, since in these tumors the ma-

Hematopoietic Growth Factors
Considerable progress has now been made in understanding
what govems proliferation and differentiation of hematopoietic
precursor cells. Not only have several of the specific growth fac-
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lignant cells are certainly related to osteoblasts. McGuire (4)
discussed surgical management of patients with skeletal tumors,
particularly from the point of view of management, but he also
described his attempts to identify specific components on the
surface ofthe malignant cells using monoclonal antibodies.

Final Note
These presentations provide aflavorof the research accomplishments in disciplines that relate in some way to metabolic
bone disease. The application of principles and methodology of
modem cell and molecular biology to these clinical problems
will be even more widespread in the future. Other technologies
particularly derived from the physical sciences will continue to
offer new approaches to diagnosis and management of skeletal
disorders. Further development of some of these approaches and
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the introduction of new surprises will certainly influence the
program of the next Henry Ford Hospital Intemational Bone and
Mineral Symposium.
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